CORONA REMEDIES
Back to Balance Sheet
|
CORONA REMEDIES Last 5 Year Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Current Liabilities | - | - | - | - |
What is the latest Current Liabilities ratio of CORONA REMEDIES ?
| Year | Current Liabilities |
|---|---|
| Mar2026 | - |
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
How is Current Liabilities of CORONA REMEDIES Trending?
| Years | Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | - | 0 | |
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | - | |
Compare Current Liabilities of peers of CORONA REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CORONA REMEDIES | ₹12,938.3 Cr | 3.5% | 8.5% | NA | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
CORONA REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CORONA REMEDIES | 3.5% |
8.5% |
|
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses